These data suggest a possible involvement of the PI3Kδ oncogenic pathway in the phosphorylation of mutated NOTCH1-ICD, and, more important, that this event may represent a new potential therapeutic target in NOTCH1-mutated CLL. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.